Synergistic Antitumoral Effect of Epigenetic Inhibitors and Gemcitabine in Pancreatic Cancer Cells

Epigenetic modifications could drive some of the molecular events implicated in proliferation, drug resistance and metastasis of pancreatic ductal adenocarcinoma (PDAC). Thus, epigenetic enzyme inhibitors could be the key to revert those events and transform PDAC into a drug-sensitive tumor. We perf...

Descripción completa

Detalles Bibliográficos
Autores principales: Maietta, Immacolata, Martínez-Pérez, Amparo, Álvarez, Rosana, De Lera, Ángel R., González-Fernández, África, Simón-Vázquez, Rosana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323654/
https://www.ncbi.nlm.nih.gov/pubmed/35890123
http://dx.doi.org/10.3390/ph15070824

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323654/
https://www.ncbi.nlm.nih.gov/pubmed/35890123
http://dx.doi.org/10.3390/ph15070824

Ejemplares similares